Kara Rushing
Family · New Albany, MSNPI 1093053977
Payments from drug & device makers
Across 147 payments — averaging $16.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$775
- AstraZeneca$274
- Amgen$231
- Lilly USA, LLC$218
- Novo Nordisk$112
- Mylan Specialty L.p.$105
- plus $647 from 16 others
What the payments were for
- Food & beverage$2,34799%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $775 |
| AstraZeneca | 15 | $274 |
| Amgen | 13 | $231 |
| Lilly USA, LLC | 14 | $218 |
| Novo Nordisk | 8 | $112 |
| Mylan Specialty L.p. | 5 | $105 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $89 |
| GSK | 5 | $84 |
| Pfizer | 4 | $78 |
| Abbott | 3 | $65 |
| Shield Therapeutics Inc | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Boston Scientific | 2 | $37 |
| Exact Sciences | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Novartis | 2 | $25 |
| Blue Earth Diagnostics | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
How this compares
$2,363 in reported general payments places this provider in the 80th percentile of 3,007 family providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 49 | $58,635 |
| JardianceEmpagliflozin | 37 | $40,309 |
| EliquisApixaban | 33 | $38,083 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $24,112 |
| MounjaroTirzepatide | 14 | $22,404 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 11 | $19,656 |
| FarxigaDapagliflozin Propanediol | 23 | $19,530 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $18,362 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $9,301 |
| Novolog FlexpenInsulin Aspart | 12 | $2,417 |
| Rosuvastatin Calcium | 114 | $2,053 |
| Gabapentin | 93 | $1,574 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 41 | $1,449 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 14 | $983 |
| Metformin Hcl ErMetformin Hcl | 35 | $980 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr | $18 | $59,96548 claims |
| Novo NordiskOzempic | $112 | $58,63549 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $274 | $43,64241 claims |
| PfizerEliquis | $78 | $38,08333 claims |
| Lilly USA, LLCMounjaro | $218 | $22,40414 claims |
| GSKTrelegy Ellipta | $84 | $18,36219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,007 family providers in Mississippi.
Other family in New Albany
- Kimberly HardinNew Albany$14K
- Cinda PerrymanFayette$888K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.